Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
15.42
Oct 22 • 3:59 PM ET Dollar change+0.13 Percentage change(0.85%)
Aftermarket Close
15.57
Aftermarket • 7:42 PM ET Dollar change+0.15 Percentage change(0.97%)
Index
-
Market Cap
383.03M
Enterprise Value
420.37M
Income
-43.08M
Sales
75.63M
Book/sh
-0.90
Cash/sh
0.45
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
226
IPO
Mar 29, 2012
P/E
-
Forward P/E
-
PEG
-
P/S
5.06
P/B
-
P/C
34.38
P/FCF
-
EV/EBITDA
-
EV/Sales
5.56
Quick Ratio
0.34
Current Ratio
0.41
Debt/Eq
-
LT Debt/Eq
-
Option/Short
Yes / Yes
EPS (ttm)
-1.44
EPS next Y
-0.38
EPS next Q
-0.24
EPS this Y
45.66%
EPS next Y
59.31%
EPS next 5Y
-
EPS past 3/5Y
-17.81% 3.38%
Sales past 3/5Y
27.66% 38.09%
EPS Y/Y TTM
26.76%
Sales Y/Y TTM
1.00%
EPS Q/Q
33.76%
Sales Q/Q
17.83%
Insider Own
1.93%
Insider Trans
10.64%
Inst Own
20.04%
Inst Trans
-2.74%
ROA
-81.36%
ROE
-1746.27%
ROIC
-
Gross Margin
81.56%
Oper. Margin
-46.57%
Profit Margin
-56.96%
SMA20
17.85%
SMA50
35.55%
SMA200
149.71%
Trades
Shs Outstand
30.93M
Shs Float
24.36M
52W High
15.64 -1.41%
52W Low
3.22 378.88%
Volatility
6.52% 5.94%
ATR (14)
0.78
RSI (14)
78.42
Beta
2.10
Rel Volume
1.45
Avg Volume
449.05K
Volume
652,649
Perf Week
14.99%
Perf Month
40.82%
Perf Quarter
234.49%
Perf Half Y
256.12%
Perf YTD
346.96%
Perf Year
289.39%
Perf 3Y
51.32%
Perf 5Y
-10.09%
Perf 10Y
48.63%
Prev Close
15.29
Price
15.42
Change %
0.85%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Woody Joseph FralinDirectorJun 09 '26Buy4.005,20020,800107,961Jun 10 09:17 PM
Woody Joseph FralinDirectorJun 09 '26Buy4.1910,00041,900102,761Jun 09 04:58 PM
Woody Joseph FralinDirectorJun 03 '26Buy4.0910,00040,94992,761Jun 05 05:00 PM
Woody Joseph FralinDirectorJun 01 '26Buy4.3010,00043,00010,000Jun 03 04:30 PM
Woody Joseph FralinDirectorJun 02 '26Buy4.1910,00041,93620,000Jun 03 04:30 PM
O'Toole David DCFOMay 20 '26Buy4.262,0008,520145,927May 20 04:30 PM
O'Toole David DCFOMay 19 '26Buy4.242,0008,480143,927May 19 04:30 PM
O'Toole David DCFOFeb 19 '26Buy4.153,00012,450140,127Feb 23 04:30 PM
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
PresidentMr. Cary G. Vance
Chief Financial OfficerMr. David O'Toole
Chief Legal & Compliance Officer & Corporate SecretaryMs. Nicole Linda Kelsey
P.M.P.Dr. Niraj Doshi J.D.
Senior Vice President of Scientific & Medical AffairsDr. Katie Bush Ph.D.